In this PharmTech video feature, we highlight the week’s industry news in an easy-to-consume, fun format. New roundups will ...

Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...

The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...

Galderma (SIX: GALD) will present data on its innovative and industry-leading neuromodulator portfolio at the TOXINS 2026 International Conference in Madrid, Spain from January 14-17, 2026. The ...

LUGANO and LUCIA are identical, double-masked noninferiority trials, with an on-label aflibercept control, developed in alignment with the U.S. Food and Drug Administration (FDA) and European ...

Medicare drug price negotiations kick-started by the Biden administration will finally result in lower drug prices for seniors beginning Jan. 1. The Medicare-negotiated price cuts will apply to 10 ...

Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become the most effective weight loss medication yet. Retatrutide is a triple-agonist ...

Please provide your email address to receive an email when new articles are posted on . An AI platform identified a significant percentage of patients with incomplete medical records. Clinicians were ...

Retatrutide works by mimicking three hunger-regulating hormones. A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising ...

A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhea, according to a Phase III trial published in The Lancet. The study found that one ...

1 Science and Information Center, Shanghai University of Traditional Chinese Medicine, Shanghai, China 2 Center for Drug Clinical Research, Institute of Interdisciplinary Integrative Medicine Research ...

The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their clinical trials. The agency gave a green light to the AI-Based Histologic ...